Wolfe Research Downgrades Boston Scientific Corporation (BSX) To Peer Perform
This marks the end of the firm’s bullish outlook on the stock for four years, with the adjustment coming after the company said sales growth of its Watchman implant, which reduces the risk of stroke...






